Results of a retrospective analysis of gemcitabine as a second-line treatment after chemoradiotherapy and maintenance chemotherapy using 5-fluorouracil in patients with locally advanced pancreatic cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/19012041

Download in:

View as

General Info

PMID
19012041